Citation only via Europe PMC

Cell therapy for age-related macular degeneration.

Mammalian genome : official journal of the International Mammalian Genome Society · 2026

Stem-cell exhaustion Review

Abstract

Age-related macular degeneration (AMD) is a major cause of vision loss worldwide. The disease is caused by deterioration of the retinal pigment epithelium (RPE), a tissue that plays critical roles in the support of the photoreceptors. Cell therapies to replace damaged RPE in the non-exudative form of AMD have been under development for several decades. We review the progress of cell therapy to date and highlight some promising future directions for research in this area.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: Europe PMC
DOI: 10.1007/s00335-026-10242-3
Canonical: link ↗
Fetched: 2026-07-02 MST

Cite this

APA

A, S., & MF., P. (2026). Cell therapy for age-related macular degeneration. <em>Mammalian genome : official journal of the International Mammalian Genome Society</em>. https://doi.org/10.1007/s00335-026-10242-3

Vancouver

A S, MF. P. Cell therapy for age-related macular degeneration. Mammalian genome : official journal of the International Mammalian Genome Society. 2026. doi:10.1007/s00335-026-10242-3.

BibTeX

@article{shaikh2026Cellth, title = {Cell therapy for age-related macular degeneration.}, author = {Shaikh A and Pera MF.}, journal = {Mammalian genome : official journal of the International Mammalian Genome Society}, year = {2026}, doi = {10.1007/s00335-026-10242-3}, }